Targeted therapies in the treatment of adult acute myeloid leukemias: current status and future perspectives
{{output}}
The rapid advancement of next-generation sequencing techniques and the identification of molecular driver events responsible for leukemia development are opening the door to new pharmacologic-targeted agents to tailor treatment of acute myeloid leukemia (AML) ... ...
